We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+6.88%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.05B
AUM Growth
+$69.3M
Cap. Flow
-$24.9M
Cap. Flow %
-1.21%
Top 10 Hldgs %
15.01%
Holding
321
New
25
Increased
77
Reduced
178
Closed
26

Top Sells

Rank Stock Value
1
XXIA
Ixia
XXIA
+$25.4M
2
LOCK
LifeLock, Inc.
LOCK
+$25M
3
MATX icon
Matsons
MATX
+$19.2M
4
COLB icon
Columbia Banking Systems
COLB
+$13.4M
5
LIVN icon
LivaNova
LIVN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.23%
2 Industrials 18.93%
3 Technology 18.08%
4 Consumer Discretionary 13.28%
5 Financials 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSP icon
201
Insperity
NSP
$1.95B
$1.97M 0.1%
44,366
-14,506
-25% -$577K
MOD icon
202
Modine Manufacturing
MOD
$10.3B
$1.95M 0.09%
+159,466
New +$1.98M
WOOF
203
DELISTED
VCA Inc.
WOOF
$1.93M 0.09%
21,110
+604
+3% +$54.2K
EEFT icon
204
Euronet Worldwide
EEFT
$2.83B
$1.91M 0.09%
+22,302
New +$1.75M
RPXC
205
DELISTED
RPX Corporation
RPXC
$1.84M 0.09%
+153,048
New +$1.74M
QCOM icon
206
Qualcomm
QCOM
$165B
$1.82M 0.09%
31,766
BOJA
207
DELISTED
Bojangles', Inc. Common Stock
BOJA
$1.82M 0.09%
+88,596
New +$1.77M
PRFT
208
DELISTED
Perficient Inc
PRFT
$1.81M 0.09%
+104,366
New +$1.86M
STBZ
209
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
$1.79M 0.09%
68,445
-1,800
-3% -$47.6K
INGN icon
210
Inogen
INGN
$178M
$1.75M 0.09%
22,499
-500
-2% -$34.6K
GBL
211
DELISTED
GAMCO Investors, Inc.
GBL
$1.74M 0.08%
58,830
-22
-0% -$663
TRS icon
212
TriMas Corp
TRS
$1.47B
$1.72M 0.08%
82,799
-2,000
-2% -$43.8K
KNL
213
DELISTED
Knoll, Inc.
KNL
$1.71M 0.08%
71,943
-1,600
-2% -$39.6K
DIS icon
214
Walt Disney
DIS
$177B
$1.7M 0.08%
15,021
-200
-1% -$22K
STM icon
215
STMicroelectronics
STM
$47.1B
$1.7M 0.08%
109,866
+3,146
+3% +$43.8K
CALX icon
216
Calix
CALX
$2.42B
$1.7M 0.08%
233,851
-6,400
-3% -$45.3K
MTRN icon
217
Materion
MTRN
$6.18B
$1.66M 0.08%
49,587
-1,000
-2% -$36.7K
ANIP icon
218
ANI Pharmaceuticals
ANIP
$1.82B
$1.6M 0.08%
32,426
-700
-2% -$39.3K
MD icon
219
Pediatrix Medical
MD
$2.13B
$1.59M 0.08%
22,994
-331
-1% -$23K
CRAI icon
220
CRA International
CRAI
$1.14B
$1.58M 0.08%
44,745
-1,200
-3% -$42K
XPO icon
221
XPO
XPO
$23.4B
$1.58M 0.08%
+95,442
New +$1.56M
BCOV
222
DELISTED
Brightcove, Inc.
BCOV
$1.55M 0.08%
174,032
+19,025
+12% +$151K
CCC
223
DELISTED
Calgon Carbon Corp
CCC
$1.53M 0.07%
104,835
-2,400
-2% -$36.9K
MED icon
224
Medifast
MED
$137M
$1.45M 0.07%
32,639
-76
-0.2% -$3.27K
LKQ icon
225
LKQ Corp
LKQ
$6.1B
$1.43M 0.07%
48,994
+1,403
+3% +$43.6K

Similar funds

Rice Hall James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Rice Hall James & Associates held 321 positions worth $2.05B, up 3.5% from $1.98B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q1 2017 filing shows 25 new, 77 increased, 178 reduced and 26 closed positions. Its largest new stake was Everforth Inc: 550,509 shares worth $26.7M. The largest sale was Ixia, an estimated $25.4M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

  • Rice Hall James & Associates's largest Q1 2017 buy was Everforth Inc: 550,509 shares worth $26.7M.
  • Rice Hall James & Associates added most to Dycom Industries in Q1 2017, an estimated $9.02M increase.
  • Rice Hall James & Associates's biggest Q1 2017 reduction was Oxford Industries, cutting an estimated $12.4M.
  • Rice Hall James & Associates fully exited Ixia in Q1 2017, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $2.05B portfolio in Q1 2017.
  • Rice Hall James & Associates opened 25 new positions and closed 26 in Q1 2017.
  • Rice Hall James & Associates's portfolio value rose 3.5% quarter-over-quarter to $2.05B.

Based on Rice Hall James & Associates's 13F filing for Q1 2017, filed 19 Apr 2017.